{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:03:11Z","timestamp":1789376591861,"version":"build-2803163510"},"reference-count":40,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"DoD\/CDMRP"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Targeted delivery of lipid nanoparticles (LNP) to immune organs remains challenging, and here we introduce a mannosylated spleen-targeted LNP (LNP-PAM) that integrates active and endogenous targeting to enhance mRNA delivery to antigen-presenting cells. A mannose-conjugated fifth lipid (PA-Mannose, PAM) was incorporated into spleen-targeted LNPs at varying molar ratios, followed by a systematic evaluation of physicochemical properties, in vitro transfection, in vivo biodistribution, cellular uptake, and mRNA expression. All formulations exhibited uniform particle size and low polydispersity, and increasing PAM content from 5% to 10% shifted LNP accumulation from the liver to the spleen, ultimately achieving exclusive spleen localization. LNP-PAM showed superior in vitro transfection in macrophages relative to conventional LNPs and higher in vivo mRNA expression in the spleen, with flow cytometry confirming preferential uptake by macrophages and type-2 conventional dendritic cells (cDC2) populations consistent with CD206-mediated endocytosis. The system maintained physicochemical stability after freeze\u2212thaw and demonstrated minimal cytotoxicity. Together, these findings indicate that mannosylation enhances spleen-targeted mRNA delivery through receptor-mediated uptake by macrophages and dendritic cells without compromising formulation robustness, positioning LNP-PAM as a practical platform for selective immune organ delivery and RNA-based immunomodulation.<\/jats:p>","DOI":"10.1021\/acsbiomaterials.6c00494","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:02:15Z","timestamp":1785970935000},"page":"4793-4802","source":"Crossref","is-referenced-by-count":0,"title":["Mannosylated Spleen-Targeted Lipid Nanoparticles Enable Enhanced mRNA Delivery to Antigen-Presenting Cells"],"prefix":"10.1021","volume":"12","author":[{"given":"Shu","family":"Zhang","sequence":"first","affiliation":[{"name":"University of Houston , , , ,","place":["Houston, Texas, United States, 77204"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"Li","sequence":"additional","affiliation":[{"name":"University of Houston , , , ,","place":["Houston, Texas, United States, 77204"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aygun","family":"Teymur","sequence":"additional","affiliation":[{"name":"University of Houston , , , ,","place":["Houston, Texas, United States, 77204"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Yang","sequence":"additional","affiliation":[{"name":"University of Houston , , , ,","place":["Houston, Texas, United States, 77204"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheereen","family":"Majd","sequence":"additional","affiliation":[{"name":"University of Houston , , , ,","place":["Houston, Texas, United States, 77204"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Mohan","sequence":"additional","affiliation":[{"name":"University of Houston , , , ,","place":["Houston, Texas, United States, 77204"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4406-1449","authenticated-orcid":true,"given":"Tianfu","family":"Wu","sequence":"additional","affiliation":[{"name":"University of Houston , , , ,","place":["Houston, Texas, United States, 77204"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"2","key":"2026091400065796600_cit1","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery","volume":"2","author":"Xu","year":"2022","journal-title":"Adv. NanoBiomed Res."},{"issue":"21","key":"2026091400065796600_cit2","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1021\/acs.accounts.1c00500","article-title":"Developing biodegradable lipid nanoparticles for intracellular mRNA delivery and genome editing","volume":"54","author":"Qiu","year":"2021","journal-title":"Acc. Chem. Res."},{"issue":"12","key":"2026091400065796600_cit3","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"6","key":"2026091400065796600_cit4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/08971900211009650","article-title":"Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273","volume":"35","author":"Teo","year":"2022","journal-title":"J. Pharm. Pract."},{"issue":"5","key":"2026091400065796600_cit5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"2026091400065796600_cit6","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1021\/acs.molpharmaceut.2c00442","article-title":"Lipid Nanoparticle (LNP) Chemistry Can Endow Unique In Vivo RNA Delivery Fates within the Liver That Alter Therapeutic Outcomes in a Cancer Model","volume":"19","author":"Johnson","year":"2022","journal-title":"Mol. Pharmaceutics"},{"issue":"4","key":"2026091400065796600_cit7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"2026091400065796600_cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtadv.2022.100299","article-title":"Fabrication of active targeting lipid nanoparticles: Challenges and perspectives","volume":"16","author":"Menon","year":"2022","journal-title":"Mater. Today Adv."},{"issue":"1","key":"2026091400065796600_cit9","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1038\/s41467-020-19486-2","article-title":"In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo","volume":"11","author":"Parayath","year":"2020","journal-title":"Nat. Commun."},{"issue":"6576","key":"2026091400065796600_cit10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"issue":"52","key":"2026091400065796600_cit11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"2026091400065796600_cit12","doi-asserted-by":"publisher","first-page":"38135","DOI":"10.1038\/s41598-025-21877-8","article-title":"Immunomodulation of behavior impairment via spleen-specific targeting lipid nanoparticles in a MeCP2 transgenic mouse model","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"2026091400065796600_cit13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2212Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"2026091400065796600_cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2022.102394","article-title":"The mannose receptor ligands and the macrophage glycome","volume":"75","author":"Cummings","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"9","key":"2026091400065796600_cit15","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1093\/nar\/gkac308","article-title":"Targeted delivery to macrophages and dendritic cells by chemically modified mannose ligand-conjugated siRNA","volume":"50","author":"Uehara","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2026091400065796600_cit16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev.immunol.17.1.593","article-title":"Mechanisms of phagocytosis in macrophages","volume":"17","author":"Aderem","year":"1999","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"2026091400065796600_cit17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00424-017-1945-7","article-title":"Physiological roles of macrophages","volume":"469","author":"Gordon","year":"2017","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"issue":"11","key":"2026091400065796600_cit18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"2026091400065796600_cit19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2015.00212","article-title":"Anatomy of a discovery: m1 and m2 macrophages","volume":"6","author":"Mills","year":"2015","journal-title":"Front. Immunol."},{"key":"2026091400065796600_cit20","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3389\/fimmu.2019.01140","article-title":"The role of monocytes and macrophages in autoimmune diseases: a comprehensive review","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Immunol."},{"key":"2026091400065796600_cit21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume-title":"Annu. Rev.","author":"Steinman","year":"1991"},{"key":"2026091400065796600_cit22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaut.2017.07.012","article-title":"Dendritic cell recruitment and activation in autoimmunity","volume":"85","author":"Sozzani","year":"2017","journal-title":"J. Autoimmun."},{"key":"2026091400065796600_cit23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2015.07.011","article-title":"Regulatory dendritic cells in autoimmunity: A comprehensive review","volume":"63","author":"Liu","year":"2015","journal-title":"J. Autoimmun."},{"issue":"7","key":"2026091400065796600_cit24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.imbio.2008.11.004","article-title":"Influence of the mannose receptor in host immune responses","volume":"214","author":"Gazi","year":"2009","journal-title":"Immunobiology"},{"issue":"6","key":"2026091400065796600_cit25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1517\/17425247.5.6.703","article-title":"Mannose-targeted systems for the delivery of therapeutics","volume":"5","author":"Irache","year":"2008","journal-title":"Expert Opin. Drug Delivery"},{"issue":"13","key":"2026091400065796600_cit26","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202318515","article-title":"Development of Mannosylated Lipid Nanoparticles for mRNA Cancer Vaccine with High Antigen Presentation Efficiency and Immunomodulatory Capability","volume":"63","author":"Lei","year":"2024","journal-title":"Angew. Chem."},{"issue":"20","key":"2026091400065796600_cit27","doi-asserted-by":"publisher","first-page":"8304","DOI":"10.1021\/acs.nanolett.2c03234","article-title":"Phosphatidylserine lipid nanoparticles promote systemic RNA delivery to secondary lymphoid organs","volume":"22","author":"Luozhong","year":"2022","journal-title":"Nano Lett."},{"issue":"1","key":"2026091400065796600_cit28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"issue":"23","key":"2026091400065796600_cit29","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1039\/D3TB00308F","article-title":"Next-generation materials for RNA\u2212lipid nanoparticles: lyophilization and targeted transfection","volume":"11","author":"Wang","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"9","key":"2026091400065796600_cit30","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1021\/acsinfecdis.9b00084","article-title":"Mannosylation of LNP results in improved potency for self-amplifying RNA (SAM) vaccines","volume":"5","author":"Goswami","year":"2019","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"2026091400065796600_cit31","doi-asserted-by":"publisher","DOI":"10.13188\/2325-4653.1000003","article-title":"Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics","volume":"1","author":"Azad","year":"2014","journal-title":"J. Cytol. Mol. Biol."},{"issue":"2","key":"2026091400065796600_cit32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/pharmaceutics13020240","article-title":"Conjugation of mannans to enhance the potency of liposome nanoparticles for the delivery of RNA vaccines","volume":"13","author":"Goswami","year":"2021","journal-title":"Pharmaceutics"},{"key":"2026091400065796600_cit33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/9781555819194.ch11","article-title":"Antigen processing and presentation mechanisms in myeloid cells","volume-title":"Myeloid Cells in Health and Disease: A Synthesis","author":"Roche","year":"2017"},{"issue":"7","key":"2026091400065796600_cit34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nri3244","article-title":"Information processing during phagocytosis","volume":"12","author":"Underhill","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"2026091400065796600_cit35","first-page":"45","article-title":"Molecular mechanisms of B cell antigen gathering and endocytosis","volume-title":"B Cell Receptor Signaling","author":"Hoogeboom","year":"2016"},{"issue":"6","key":"2026091400065796600_cit36","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.ymthe.2022.04.011","article-title":"Pro-inflammatory concerns with lipid nanoparticles","volume":"30","author":"Moghimi","year":"2022","journal-title":"Mol. Ther."},{"key":"2026091400065796600_cit37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jconrel.2022.11.022","article-title":"Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines","volume":"353","author":"Kim","year":"2023","journal-title":"J. Controlled Release"},{"issue":"26","key":"2026091400065796600_cit38","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202405444","article-title":"One-component cationic lipids for systemic mRNA delivery to splenic T cells","volume":"136","author":"Zhang","year":"2024","journal-title":"Am. Ethnol."},{"key":"2026091400065796600_cit39","first-page":"20210146","article-title":"From structural design to delivery: mRNA therapeutics for cancer immunotherapy","volume-title":"Exploration","author":"Zhou","year":"2024"},{"issue":"32","key":"2026091400065796600_cit40","doi-asserted-by":"publisher","first-page":"28665","DOI":"10.1021\/jacs.5c01389","article-title":"Carbonate-Bearing Ionizable Lipids for mRNA Delivery to Splenic NK Cells","volume":"147","author":"Wu","year":"2025","journal-title":"J. Am. Chem. Soc."}],"container-title":["ACS Biomaterials Science &amp; Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsbiomaterials.6c00494","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/abseba\/article-pdf\/12\/9\/4793\/66419767\/ab-2026-00494q.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/abseba\/article-pdf\/12\/9\/4793\/66419767\/ab-2026-00494q.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:10:05Z","timestamp":1789373405000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/abseba\/article\/12\/9\/4793\/5246573\/Mannosylated-Spleen-Targeted-Lipid-Nanoparticles"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,5]]},"published-print":{"date-parts":[[2026,9,14]]}},"URL":"https:\/\/doi.org\/10.1021\/acsbiomaterials.6c00494","relation":{},"ISSN":["2373-9878"],"issn-type":[{"value":"2373-9878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}